PATH
PATH is an international organization that drives transformative innovation to save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity.
By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.
New tools in the treatment of P. vivax malaria
Highlights from UNGA 80: Advancing Access and Financing for NCD Medicines and Products
Expanding the impact of malaria chemoprevention
The future of malaria vaccines: Innovation, access, and impact
Global South Learning Exchange: Advancing Large-Scale Food Fortification in the Global South
Can AI support health care workers in delivering better care?
[TEASER] Can AI support health care workers in delivering better care?
Introducing PATH’s Women’s Health Initiative
Sustainable financing 2030: Accelerating integrated, country-owned HIV responses
Making Every Baby Count Initiative (MEBCI): Phase 2.0
The future of AI in African health care settings
Advancing health equity in India: PATH's journey
Start with the hardest to reach: A new test and treatment for relapsing P. vivax malaria in Brazil
The European Union as a strategic platform for global health
Nepal's first human milk bank: Ensuring access to lifesaving human milk for sick newborns
Local Manufacturing to Achieve Global Health Equity
A day in the life of malaria mosquito collectors
Lessons learned, challenges, and opportunities for national, regional, and global MNCH advocacy
PATH Advocacy & Public Policy: Capacity Building | Stories from Uganda
PATH Advocacy & Public Policy: Immunization | Stories from Uganda
Truly global health: International lessons for US health systems
Why do floods cause human-animal infections?
Nick Luter, Sr. Market Dynamics Program Officer, at MedTrop 2023 in Brazil
Understanding the impact of COVID-19 self-testing in Brazil
We are Not Waiting! Let's join hands to act against Viral Hepatitis in South Asia
Increasing access to medical oxygen: Action to ensure sustained gains.
Connected diagnostics: Do the benefits outweigh the costs?
Unlocking new approaches, tools, and financing for next-generation health systems
Making the case for oxygen: Ensuring continued investment in medical oxygen systems
Advancing vaccine coverage: How human-centered design is being used to motivate immunization workers